[{"Assets_0_Q3_USD":437936000.0,"CommonStockSharesOutstanding_0_Q3_shares":29603852.0,"NetIncomeLoss_1_Q3_USD":-6230000.0,"NetIncomeLoss_3_Q3_USD":-32347000.0,"StockholdersEquity_0_Q3_USD":244239000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29513842.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29343291.0,"Ticker":"NVRO","CIK":"1444380","name":"NEVRO CORP","OfficialName":"Nevro Corp. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2648227724.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20171106"}]